Elliott M - Search Results

1

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.

Maini RN, Brennan FM, Williams R, Chu CQ, Cope AP, Gibbons D, Elliott M, Feldmann M. Maini RN, et al. Among authors: elliott m. Clin Exp Rheumatol. 1993 Mar-Apr;11 Suppl 8:S173-5. Clin Exp Rheumatol. 1993. PMID: 8391952 Review.

2

Targeting TNF alpha for the therapy of rheumatoid arthritis.

Maini RN, Elliott M, Brennan FM, Williams RO, Feldmann M. Maini RN, et al. Among authors: elliott m. Clin Exp Rheumatol. 1994 Nov-Dec;12 Suppl 11:S63-6. Clin Exp Rheumatol. 1994. PMID: 7768056 Review.

3

TNF alpha as a therapeutic target in rheumatoid arthritis.

Feldmann M, Brennan FM, Elliott M, Katsikis P, Maini RN. Feldmann M, et al. Among authors: elliott m. Circ Shock. 1994 Aug;43(4):179-84. Circ Shock. 1994. PMID: 7895323 Review.

4

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.

Maini RN, Elliott M, Brennan FM, Williams RO, Feldmann M. Maini RN, et al. Among authors: elliott m. APMIS. 1997 Apr;105(4):257-63. doi: 10.1111/j.1699-0463.1997.tb00567.x. APMIS. 1997. PMID: 9164467 Review.

5

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.

Davis D, Charles PJ, Potter A, Feldmann M, Maini RN, Elliott MJ. Davis D, et al. Among authors: elliott mj. Br J Rheumatol. 1997 Sep;36(9):950-6. doi: 10.1093/rheumatology/36.9.950. Br J Rheumatol. 1997. PMID: 9376990 Clinical Trial.

6

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, Antoni C, Leeb B, Elliott MJ, Woody JN, Schaible TF, Feldmann M. Maini RN, et al. Among authors: elliott mj. Arthritis Rheum. 1998 Sep;41(9):1552-63. doi: 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W. Arthritis Rheum. 1998. PMID: 9751087 Clinical Trial.

7

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.

Charles P, Elliott MJ, Davis D, Potter A, Kalden JR, Antoni C, Breedveld FC, Smolen JS, Eberl G, deWoody K, Feldmann M, Maini RN. Charles P, et al. Among authors: elliott mj. J Immunol. 1999 Aug 1;163(3):1521-8. J Immunol. 1999. PMID: 10415055 Clinical Trial.

8

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.

Taylor PC, Peters AM, Paleolog E, Chapman PT, Elliott MJ, McCloskey R, Feldmann M, Maini RN. Taylor PC, et al. Among authors: elliott mj. Arthritis Rheum. 2000 Jan;43(1):38-47. doi: 10.1002/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L. Arthritis Rheum. 2000. PMID: 10643698 Free article.

9

TNF alpha is an effective therapeutic target for rheumatoid arthritis.

Feldmann M, Brennan FM, Elliott MJ, Williams RO, Maini RN. Feldmann M, et al. Among authors: elliott mj. Ann N Y Acad Sci. 1995 Sep 7;766:272-8. doi: 10.1111/j.1749-6632.1995.tb26675.x. Ann N Y Acad Sci. 1995. PMID: 7486670 Review.

10

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.

Elliott MJ, Feldmann M, Maini RN. Elliott MJ, et al. Int J Immunopharmacol. 1995 Feb;17(2):141-5. doi: 10.1016/0192-0561(94)00092-3. Int J Immunopharmacol. 1995. PMID: 7544768 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,238 results

Search Page

Filters